HEADER PROTEIN BINDING/TRANSCRIPTION 30-MAY-19 6K5R TITLE COMPLEX OF SUMO2 WITH PHOSPHORYLATED VIRAL SIM IE2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SMALL UBIQUITIN-RELATED MODIFIER 3; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: SMALL UBIQUITIN LIKE MODIFIER 2, SUMO-3,SMT3 HOMOLOG 1,SUMO- COMPND 5 2,UBIQUITIN-LIKE PROTEIN SMT3A,SMT3A; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: ASP-THR-ALA-GLY-CYS-ILE-VAL-ILE-SEP-ASP-SEP-GLU; COMPND 9 CHAIN: B; COMPND 10 SYNONYM: VIRAL TRANSCRIPTION FACTOR IE2, IE2,PROTEIN UL122; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SUMO3, SMT3A, SMT3H1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: HUMAN CYTOMEGALOVIRUS (STRAIN AD169); SOURCE 11 ORGANISM_COMMON: HHV-5; SOURCE 12 ORGANISM_TAXID: 10360 KEYWDS COMPLEX, PROTEIN BINDING-TRANSCRIPTION COMPLEX EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR K.S.CHATTERJEE,R.DAS REVDAT 2 25-DEC-19 6K5R 1 JRNL REVDAT 1 07-AUG-19 6K5R 0 JRNL AUTH V.TRIPATHI,K.S.CHATTERJEE,R.DAS JRNL TITL CASEIN KINASE-2-MEDIATED PHOSPHORYLATION INCREASES THE JRNL TITL 2 SUMO-DEPENDENT ACTIVITY OF THE CYTOMEGALOVIRUS JRNL TITL 3 TRANSACTIVATOR IE2. JRNL REF J.BIOL.CHEM. V. 294 14546 2019 JRNL REFN ESSN 1083-351X JRNL PMID 31371453 JRNL DOI 10.1074/JBC.RA119.009601 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : HADDOCK REMARK 3 AUTHORS : BONVIN REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6K5R COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 31-MAY-19. REMARK 100 THE DEPOSITION ID IS D_1300011948. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.4 REMARK 210 IONIC STRENGTH : 162.7 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 0.3 MM [U-15N] SUMO2, 3 MM REMARK 210 PHOSPHORYLATED SIM FROM VIRAL REMARK 210 PROTEIN IE2, 90% H2O/10% D2O; 1 REMARK 210 MM [U-13C; U-15N] SUMO2, 1.5 MM REMARK 210 PHOSPHORYLATED SIM FROM VIRAL REMARK 210 PROTEIN IE2, 90% H2O/10% D2O; 3 REMARK 210 MM PHOSPHORYLATED SIM FROM VIRAL REMARK 210 PROTEIN IE2, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC; REMARK 210 2D 1H-1H TOCSY; 2D 1H-1H NOESY; REMARK 210 3D HALF FILTERED NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE, SPARKY REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASP A 26 HG SER A 28 1.59 REMARK 500 HZ1 LYS A 42 OD2 ASP B 204 1.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 5 THR A 70 29.30 -140.59 REMARK 500 9 THR A 70 24.02 -142.92 REMARK 500 10 THR A 70 45.99 -147.90 REMARK 500 10 GLU A 81 30.43 70.58 REMARK 500 10 THR A 91 34.16 -99.79 REMARK 500 11 LYS A 45 -38.34 -135.30 REMARK 500 13 ASP A 26 -63.60 -107.35 REMARK 500 18 THR A 70 18.90 -141.39 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 36259 RELATED DB: BMRB REMARK 900 COMPLEX OF SUMO2 WITH PHOSPHORYLATED VIRAL SIM IE2 DBREF 6K5R A 16 92 UNP P55854 SUMO3_HUMAN 15 91 DBREF 6K5R B 195 206 UNP P19893 VIE2_HCMVA 195 206 SEQRES 1 A 77 ASP HIS ILE ASN LEU LYS VAL ALA GLY GLN ASP GLY SER SEQRES 2 A 77 VAL VAL GLN PHE LYS ILE LYS ARG HIS THR PRO LEU SER SEQRES 3 A 77 LYS LEU MET LYS ALA TYR CYS GLU ARG GLN GLY LEU SER SEQRES 4 A 77 MET ARG GLN ILE ARG PHE ARG PHE ASP GLY GLN PRO ILE SEQRES 5 A 77 ASN GLU THR ASP THR PRO ALA GLN LEU GLU MET GLU ASP SEQRES 6 A 77 GLU ASP THR ILE ASP VAL PHE GLN GLN GLN THR GLY SEQRES 1 B 12 ASP THR ALA GLY CYS ILE VAL ILE SEP ASP SEP GLU MODRES 6K5R SEP B 203 SER MODIFIED RESIDUE MODRES 6K5R SEP B 205 SER MODIFIED RESIDUE HET SEP B 203 14 HET SEP B 205 14 HETNAM SEP PHOSPHOSERINE HETSYN SEP PHOSPHONOSERINE FORMUL 2 SEP 2(C3 H8 N O6 P) HELIX 1 AA1 LEU A 40 GLY A 52 1 13 SHEET 1 AA1 6 GLN A 65 PRO A 66 0 SHEET 2 AA1 6 ILE A 58 PHE A 62 -1 N PHE A 62 O GLN A 65 SHEET 3 AA1 6 THR A 83 GLN A 88 -1 O PHE A 87 N ARG A 59 SHEET 4 AA1 6 ILE A 18 ALA A 23 1 N LYS A 21 O ILE A 84 SHEET 5 AA1 6 VAL A 29 ILE A 34 -1 O ILE A 34 N ILE A 18 SHEET 6 AA1 6 ALA B 197 VAL B 201 1 O GLY B 198 N GLN A 31 LINK C ILE B 202 N SEP B 203 1555 1555 1.32 LINK C SEP B 203 N ASP B 204 1555 1555 1.32 LINK C ASP B 204 N SEP B 205 1555 1555 1.32 LINK C SEP B 205 N GLU B 206 1555 1555 1.33 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1